Valuation: Lavipharm S.A.

Market Cap 27Cr 31Cr 25Cr 23Cr 43Cr 2.95TCr 43Cr 293Cr 114.81Cr 1.48TCr 115.86Cr 113.35Cr 4.92TCr P/E 2024
14.9x
P/E 2025 27.9x
Enterprise Value 29Cr 34Cr 27Cr 25Cr 47Cr 3.25TCr 48Cr 322.33Cr 126.31Cr 1.63TCr 127.46Cr 124.7Cr 5.41TCr EV / Sales 2024
3.07x
EV / Sales 2025 3.04x
Free-Float
39.31%
Yield 2024
2.52%
Yield 2025 -
1 day+0.26%
1 week+0.26%
Current month-1.64%
1 month+8.61%
3 months-1.14%
6 months+17.24%
Current year+61.24%
1 week 1.54
Extreme 1.54
1.59
1 month 1.4
Extreme 1.4
1.65
Current year 0.94
Extreme 0.937
1.74
1 year 0.76
Extreme 0.756
1.74
3 years 0.58
Extreme 0.584
1.74
5 years 0.35
Extreme 0.346
2.22
10 years 0.16
Extreme 0.162
2.22
Manager TitleAgeSince
Director of Finance/CFO - 01/12/2021
Chief Tech/Sci/R&D Officer - -
Compliance Officer - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member 76 -
Chairman 86 01/01/2021
Date Insider Type Main position Quantity % Market Cap.
12/02/25 Buy

Chief Financial Officer

20,000 0.0119%
27/05/23 Sell 35,434 0.0189%
28/03/23 Buy

Chief Financial Officer

23,455 0.0125%
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%+0.26%+90.96%+120.90% 31Cr
-2.49%-3.24%+14.66%+64.56% 4.84TCr
-0.12%-5.43%+52.28%+115.90% 3.97TCr
-1.28%-2.21%-8.47%+15.11% 1.23TCr
-0.33%+1.55%+14.43%+72.12% 1.18TCr
-0.58%-0.77%+29.90%+141.59% 906.17Cr
0.00%+1.64%+22.99%+39.94% 756.57Cr
-0.88%+1.18%+40.97%-13.86% 717.59Cr
+0.46%+2.19%+13.91%+192.06% 684.21Cr
+0.63%-2.53%-30.10%+23.84% 576.86Cr
Average -0.43%+0.29%+24.15%+77.22% 1.49TCr
Weighted average by Cap. -1.00%-1.22%+23.78%+78.84%

Financials

2024 2025
Net sales 5.29Cr 6.13Cr 4.97Cr 4.52Cr 8.51Cr 586.39Cr 8.62Cr 58Cr 23Cr 293.78Cr 23Cr 23Cr 977.25Cr 6.26Cr 7.25Cr 5.87Cr 5.35Cr 10Cr 693.14Cr 10Cr 69Cr 27Cr 347.26Cr 27Cr 27Cr 1.16TCr
Net income 89.82L 1.04Cr 84.27L 76.75L 1.44Cr 99Cr 1.46Cr 9.88Cr 3.87Cr 50Cr 3.91Cr 3.82Cr 165.79Cr 59.86L 69.34L 56.16L 51.15L 96.18L 66Cr 97.51L 6.58Cr 2.58Cr 33Cr 2.6Cr 2.55Cr 110.49Cr
Net Debt 2.83Cr 3.28Cr 2.66Cr 2.42Cr 4.55Cr 313.82Cr 4.62Cr 31Cr 12Cr 157.22Cr 12Cr 12Cr 522.99Cr 2.67Cr 3.09Cr 2.5Cr 2.28Cr 4.29Cr 295.41Cr 4.34Cr 29Cr 11Cr 148Cr 12Cr 11Cr 492.32Cr
Logo Lavipharm S.A.
Lavipharm SA is a Greece-based pharmaceutical and healthcare company engaged in the research and development of drug delivery solutions and the commercialisation of pharmaceutical, over-the-counter (OTC) and related healthcare products. It is active in the provision of prescription medicines, OTC products and food supplements, supported by integrated activities across research and development, manufacturing and commercial operations. It maintains a portfolio focused primarily on therapeutic areas including cardiology, central nervous system disorders, urology, oncology and chronic pain, supplying solutions designed for healthcare professionals and patients. The Company operates in both domestic and international markets and combines product development capabilities with market access and distribution activities, while acting as the parent entity of the Lavipharm Group through which its broader operations are conducted.
Employees
285
Date Price Change Volume
17/26/17 1.564 +0.26% 8,975
14/26/14 €1.560 0.00% 5,223
13/26/13 €1.560 -0.64% 25,588
12/26/12 €1.570 +0.26% 9,742
11/26/11 €1.566 +0.38% 37,104
  1. Stock Market
  2. Stocks
  3. LAVI Stock